ArticleResearch and practice in thrombosis and haemostasis2025

Stepwise response-guided treatment protocol superior to thrombopoietin receptor agonist-based second-line therapy for severe persistent/chronic immune thrombocytopenia: a multicenter prospective study from China.

Lingling Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.